Introduction Tuberculosis (TB) is the most common serious opportunistic infection among
people with Human Immunodeficiency Virus (HIV) infection and are considered as the …

There have been limited studies linking baseline factors, including the viral load (VL) test,
with virological non-suppression since the introduction of dolutegravir (DTG)-based …

Background Treatment with effective antiretroviral therapy (ART) reduces viral load as well
as HIV-related morbidity and mortality in HIV-positive patients. Despite the expanded …

Several efforts to repurpose drugs for COVID-19 treatment have largely either failed to
identify a suitable agent or agents identified did not translate to clinical use. Reasons that …

Objectives To assess whether a single instance of low-level viraemia (LLV) is associated
with the presence of drug resistance mutations (DRMs) and predicts subsequent virological …

Abstract Background In Equatorial Guinea, only 54% of people living with HIV know their
HIV status. There are no confirmatory or molecular diagnostic techniques for early diagnosis …

Background Lesotho has the second-highest HIV prevalence globally at an estimated 23%,
with approximately 87% of the population between 15 and 59 years of age reported to be …

Background Ethiopia's viral suppression rate was less than 90% by 2020, and more than
10% of adult clients on ART in Woliso Town were unsuppressed at the end of March 2022 …

Background: The growing number of people on antiretroviral therapy in Kenya has led to a
decrease in HIV morbidity and mortality. However, virologic failure (VF) threatens to reverse …

Several efforts to repurpose drugs for COVID-19 treatment have largely either failed to
identify a suitable agent or agents identified did not translate to clinical use; either because …